CARL · Carlsmed, Inc. · Financials
Market Cap
$420.46M
Shares
27.30M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$50.51M
+85.9%
FY2025
Net Income
-$29.63M
-22.2%
FY2025
Gross Margin
75.31%
+1.5pp
FY2025
Operating Margin
-60.53%
+28.3pp
FY2025
Diluted EPS
-$2.12
+65.3%
FY2025
Operating Cash Flow
-$28.98M
-13.8%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 |
|---|---|---|---|---|
| $74M – $78M | $63.3M | $50.51M | $27.17M | |
| — | $14.79M | $12.47M | $7.12M | |
| — | $48.5M | $38.04M | $20.05M | |
| — | — | 75.31% | 73.8% | |
| — | $20.93M | $17.02M | $14.3M | |
| — | $42.64M | $35.03M | $21.47M | |
| — | $23.6M | $16.57M | $8.39M | |
| — | $409K | $281K | $145K | |
| — | $87.17M | $68.61M | $44.17M | |
| — | -$38.67M | -$30.57M | -$24.12M | |
| — | — | -60.53% | -88.8% | |
| — | -$38.26M | -$30.29M | -$23.98M | |
| — | $1.33M | $1.43M | $1.32M | |
| — | $3.71M | $2.7M | $1.33M | |
| — | $2.32M | $940K | -$135K | |
| — | $0 | $0 | $0 | |
| — | -$36.35M | -$29.63M | -$24.26M | |
| — | — | -58.67% | -89.3% | |
| — | -$36.35M | -$30.22M | -$24.85M | |
| — | -$36.36M | -$29.63M | -$24.26M | |
| USD/shares | — | $0.11 | -$2.12 | -$6.11 |
| USD/shares | — | $0.11 | -$2.12 | -$6.11 |
| shares | — | — | 14.22M | 4.07M |
| shares | — | — | 14.22M | 4.07M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
5.78×
Peer median 1.56×
EV/EBIT
—
Peer median 43.98×
P/E (TTM)
—
Peer median 43.24×
Peer medians compare against the 23 similar-size Health Information Services companies (of 45 listed).